CGTX
Price
$2.61
Change
+$0.02 (+0.77%)
Updated
Sep 5 closing price
Capitalization
230.26M
67 days until earnings call
SNDX
Price
$17.04
Change
+$0.85 (+5.25%)
Updated
Sep 5 closing price
Capitalization
1.47B
66 days until earnings call
Interact to see
Advertisement

CGTX vs SNDX

Header iconCGTX vs SNDX Comparison
Open Charts CGTX vs SNDXBanner chart's image
Cognition Therapeutics
Price$2.61
Change+$0.02 (+0.77%)
Volume$4.67M
Capitalization230.26M
Syndax Pharmaceuticals
Price$17.04
Change+$0.85 (+5.25%)
Volume$2.73M
Capitalization1.47B
CGTX vs SNDX Comparison Chart in %
Loading...
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGTX vs. SNDX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGTX is a StrongBuy and SNDX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CGTX: $2.61 vs. SNDX: $17.04)
Brand notoriety: CGTX and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGTX: 32% vs. SNDX: 116%
Market capitalization -- CGTX: $230.26M vs. SNDX: $1.47B
CGTX [@Biotechnology] is valued at $230.26M. SNDX’s [@Biotechnology] market capitalization is $1.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGTX’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • CGTX’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDX is a better buy in the long-term than CGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGTX’s TA Score shows that 4 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • CGTX’s TA Score: 4 bullish, 5 bearish.
  • SNDX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CGTX and SNDX are a bad buy in the short-term.

Price Growth

CGTX (@Biotechnology) experienced а +7.41% price change this week, while SNDX (@Biotechnology) price change was +4.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

CGTX is expected to report earnings on Nov 12, 2025.

SNDX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.47B) has a higher market cap than CGTX($230M). CGTX YTD gains are higher at: 272.166 vs. SNDX (28.896). CGTX has higher annual earnings (EBITDA): -32.73M vs. SNDX (-314.25M). SNDX has more cash in the bank: 469M vs. CGTX (10.7M). CGTX has less debt than SNDX: CGTX (468K) vs SNDX (1.68M). SNDX has higher revenues than CGTX: SNDX (77.9M) vs CGTX (0).
CGTXSNDXCGTX / SNDX
Capitalization230M1.47B16%
EBITDA-32.73M-314.25M10%
Gain YTD272.16628.896942%
P/E RatioN/AN/A-
Revenue077.9M-
Total Cash10.7M469M2%
Total Debt468K1.68M28%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGTXSNDX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 30 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPGPF3.04N/A
N/A
PageGroup PLC
NLPXF0.03N/A
N/A
Noble Mineral Exploration, Inc.
ROHCF14.45N/A
N/A
Rohm Co. Ltd.
TRVR35.00N/A
N/A
Two Rivers Financial Group, Inc.
DNKEY20.33-0.16
-0.78%
Danske Bank A/S

CGTX and

Correlation & Price change

A.I.dvisor tells us that CGTX and SNDX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGTX and SNDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGTX
1D Price
Change %
CGTX100%
+0.77%
SNDX - CGTX
32%
Poorly correlated
+5.25%
RGNX - CGTX
30%
Poorly correlated
+3.08%
BRCTF - CGTX
30%
Poorly correlated
N/A
LGVN - CGTX
29%
Poorly correlated
+5.84%
KALV - CGTX
29%
Poorly correlated
+4.08%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with REPL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+5.25%
REPL - SNDX
50%
Loosely correlated
+8.95%
CGON - SNDX
48%
Loosely correlated
+6.88%
ETNB - SNDX
47%
Loosely correlated
+3.02%
IDYA - SNDX
47%
Loosely correlated
+5.15%
RNA - SNDX
47%
Loosely correlated
+3.90%
More